155 related articles for article (PubMed ID: 17286149)
1. Evaluation of the effects of hydrophilic organic solvents on CYP3A-mediated drug-drug interaction in vitro.
Iwase M; Kurata N; Ehana R; Nishimura Y; Masamoto T; Yasuhara H
Hum Exp Toxicol; 2006 Dec; 25(12):715-21. PubMed ID: 17286149
[TBL] [Abstract][Full Text] [Related]
2. Impact of organic solvents on cytochrome P450 probe reactions: filling the gap with (S)-Warfarin and midazolam hydroxylation.
González-Pérez V; Connolly EA; Bridges AS; Wienkers LC; Paine MF
Drug Metab Dispos; 2012 Nov; 40(11):2136-42. PubMed ID: 22896727
[TBL] [Abstract][Full Text] [Related]
3. The xenobiotic inhibitor profile of cytochrome P4502C8.
Ong CE; Coulter S; Birkett DJ; Bhasker CR; Miners JO
Br J Clin Pharmacol; 2000 Dec; 50(6):573-80. PubMed ID: 11136296
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
Gibbs MA; Thummel KE; Shen DD; Kunze KL
Drug Metab Dispos; 1999 Feb; 27(2):180-7. PubMed ID: 9929500
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.
Patki KC; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Jul; 31(7):938-44. PubMed ID: 12814972
[TBL] [Abstract][Full Text] [Related]
6. Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent.
Wang RW; Newton DJ; Liu N; Atkins WM; Lu AY
Drug Metab Dispos; 2000 Mar; 28(3):360-6. PubMed ID: 10681383
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a highly selective CYP3A4 inhibitor suitable for reaction phenotyping studies and differentiation of CYP3A4 and CYP3A5.
Li X; Song X; Kamenecka TM; Cameron MD
Drug Metab Dispos; 2012 Sep; 40(9):1803-9. PubMed ID: 22696420
[TBL] [Abstract][Full Text] [Related]
8. Effects of acetone, acetonitrile, ethanol, methanol and DMSO on cytochrome P450 in rainbow trout (Oncorhynchus mykiss) hepatic microsomes.
Sakalli S; Burkina V; Zlabek V; Zamaratskaia G
Toxicol Mech Methods; 2015; 25(6):501-6. PubMed ID: 26275123
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
10. Effect of ion suppression on judgment of enzyme inhibition and avoidance of error by utilizing a stable isotope-labeled probe substrate: example of CYP3A4 inhibition with [13C4,15N] labeled midazolam as a substrate.
Nakamura K; Watanabe A; Okudaira N; Okazaki O; Sudo K
Drug Metab Pharmacokinet; 2007 Apr; 22(2):113-8. PubMed ID: 17495418
[TBL] [Abstract][Full Text] [Related]
11. Effect of regular organic solvents on cytochrome P450-mediated metabolic activities in rat liver microsomes.
Li D; Han Y; Meng X; Sun X; Yu Q; Li Y; Wan L; Huo Y; Guo C
Drug Metab Dispos; 2010 Nov; 38(11):1922-5. PubMed ID: 20729275
[TBL] [Abstract][Full Text] [Related]
12. Activation of CYP3A-mediated testosterone 6β-hydroxylation by tanshinone IIA and midazolam 1-hydroxylation by cryptotanshinone in human liver microsomes.
Qiu F; Zhang R; Wang G; Gao C; Sun J; Jiang J; Ma Y
Xenobiotica; 2010 Dec; 40(12):800-6. PubMed ID: 20964620
[TBL] [Abstract][Full Text] [Related]
13. Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible.
Stresser DM; Broudy MI; Ho T; Cargill CE; Blanchard AP; Sharma R; Dandeneau AA; Goodwin JJ; Turner SD; Erve JC; Patten CJ; Dehal SS; Crespi CL
Drug Metab Dispos; 2004 Jan; 32(1):105-12. PubMed ID: 14709627
[TBL] [Abstract][Full Text] [Related]
14. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
Palamanda J; Feng WW; Lin CC; Nomeir AA
Drug Metab Dispos; 2000 Jan; 28(1):38-43. PubMed ID: 10611138
[TBL] [Abstract][Full Text] [Related]
16. Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors.
Martínez C; Gervasini G; Agúndez JA; Carrillo JA; Ramos SI; García-Gamito FJ; Gallardo L; Benítez J
Eur J Clin Pharmacol; 2000 May; 56(2):145-51. PubMed ID: 10877009
[TBL] [Abstract][Full Text] [Related]
17. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes.
Chauret N; Gauthier A; Nicoll-Griffith DA
Drug Metab Dispos; 1998 Jan; 26(1):1-4. PubMed ID: 9443844
[TBL] [Abstract][Full Text] [Related]
18. Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. II: establishment and evaluation of dexamethasone-pretreated female rats.
Kanazu T; Yamaguchi Y; Okamura N; Baba T; Koike M
Xenobiotica; 2004 May; 34(5):403-13. PubMed ID: 15370957
[TBL] [Abstract][Full Text] [Related]
19. Allosteric activation of midazolam CYP3A5 hydroxylase activity by icotinib - Enhancement by ketoconazole.
Zhuang X; Zhang T; Yue S; Wang J; Luo H; Zhang Y; Li Z; Che J; Yang H; Li H; Zhu M; Lu C
Biochem Pharmacol; 2016 Dec; 121():67-77. PubMed ID: 27666601
[TBL] [Abstract][Full Text] [Related]
20. Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate.
Polasek TM; Miners JO
Eur J Clin Pharmacol; 2006 Mar; 62(3):203-8. PubMed ID: 16416302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
